logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Malignant Neoplasm Of Thyroid

    FiltersReset Filters
    4 results

    • levothyroxine sodium

      (levothyroxine sodium)
      YARAL Pharma Inc.
      Usage: Levothyroxine Sodium is indicated for replacement therapy in hypothyroidism for patients aged 6 years and older, and for TSH suppression in managing well-differentiated thyroid cancer post-surgery and radioiodine therapy. It is not for treating benign thyroid nodules or transient hypothyroidism during recovery from subacute thyroiditis.

    • liothyronine sodium

      (Liothyronine Sodium)
      Mayne Pharma Commercial LLC
      Usage: Liothyronine sodium tablets are indicated for replacement therapy in hypothyroidism (primary, secondary, tertiary), as an adjunctive treatment in thyroid cancer management, and for use in thyroid suppression tests to evaluate suspected mild hyperthyroidism. They are not indicated for benign nodules or subacute thyroiditis recovery.

    • retevmo

      (selpercatinib)
      Eli Lilly and Company
      Usage: RETEVMO is indicated for adult and pediatric patients aged 2 years and older with RET fusion-positive non-small cell lung cancer, RET-mutant advanced medullary thyroid cancer, RET fusion-positive advanced thyroid cancer, and RET fusion-positive solid tumors that require systemic therapy, following specific testing.

    • synthroid

      (Levothyroxine Sodium)
      AbbVie Inc.
      Usage: SYNTHROID is indicated for replacement therapy in congenital or acquired hypothyroidism in patients of all ages. It is also used as an adjunct in managing well-differentiated thyroid cancer. It is not indicated for benign thyroid nodules or during recovery from subacute thyroiditis.